Sage Journals: Discover world-class research

Open access

Review article

First published 2022

What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review

Marie-Hélène Lafage-Proust

Therapeutic Advances in Rare Disease

Open access

Research article

First published 2026-2

Two-year structural skeletal outcomes of burosumab therapy in pediatric X-linked hypophosphatemia: A radiographic cohort study

Hayeon Lim, Wonik Lee, Naye Choi [...]

Journal of Children's Orthopaedics

Open access

Research article

First published 2024

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Annemieke M. Boot, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Open access

Research article

First published 2022

Post-authorisation safety study of burosumab use in paediatric,adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Maria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Open access

Research article

First published 2021

Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy

Avivit Brener, Yael Lebenthal, Roxana Cleper [...]

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2023-06

Efficacy of Burosumab Every 2 Weeks in an Adult with X-Linked Hypophosphatemia: Should We Learn from Children?

Alessia Marcellino, Silvia Bloise, Carmelo Pirone [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Review article

First published 2025

Update on the medical management of fibrous dysplasia of the bone

Kelly L. Wentworth, Jeayoung Park, Xiaobing Yu [...]

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Review article

First published 2018-6

Tumor-induced osteomalacia

Robert F Reilly

Journal of Onco-Nephrology

Search results